logo

For the Inventor, By the Inventor

Philadelphia, PA, United States of America

Eric L Meggers

This inventor holds 18 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents, primarily in Biotechnology Innovations. Top assignees: Scripps Research Institute, University of California, University of Pennsylvania. Active years: 2006-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric L Meggers. Retrieved from https://idiyas.com/inventor/eric-l-meggers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 55.6



Average Co-Inventor Count = 6.3

ph-index = 14

Forward Citations = 992(Granted Patents)


Location History:

  • La Jolla, CA (US) (2006)
  • Philadelphia, PA (US) (2006 - 2012)
  • Marburg, DE (2015)

Company Filing History:

goldMedal14 out of 1,209 
 
Scripps Research Institute
 patents
silverMedal14 out of 16,082 
 
University of California
 patents
bronzeMedal3 out of 2,668 
 
University of Pennsylvania
 patents
4. 1 out of 5 
 
The Trustees of the University of Pennyslvania
 patents
5. 1 out of 247 
 
The Wistar Institute
 patents
where one patent can have more than one assignee

Years Active: 2006-2015

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Orthogonal tRNA
Aminoacyl tRNA Synthetase
Unnatural Amino Acids
Metal Complex Inhibitors
Phosphatidyl-Inositol-3-Kinase
Glycogen Synthase Kinase 3
Protein Kinase Inhibitors
Biotechnology
Compositions
Production Methods
In Vivo Incorporation
18 patents (USPTO):Explore Patents
1. 9163271 - Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs (2015-10-20),
2. 8183012 - Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs (2012-05-22),
3. 8173392 - In vivo incorporation of unnatural amino acids (2012-05-08),
4. 8173364 - Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs (2012-05-08),
5. 8114648 - In vivo incorporation of unnatural amino acids (2012-02-14),
6. 8106039 - Metal complex phosphatidyl-inositol-3-kinase inhibitors (2012-01-31),
7. 8080660 - Metal complex glycogen synthase kinase 3 inhibitors (2011-12-20),
8. 8030074 - In vivo incorporation of unnatural amino acids (2011-10-04),
9. 8012739 - Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase pairs (2011-09-06),
10. 7915025 - In vivo incorporation of unnatural amino acids (2011-03-29),
11. 7713721 - Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs (2010-05-11),
12. 7671046 - Metal complex protein kinase inhibitors (2010-03-02),
13. 7638300 - In vivo incorporation of unnatural amino acids (2009-12-29),
14. 7488817 - Metal complex protein kinase inhibitors (2009-02-10),
15. 7368275 - In vivo incorporation of unnatural amino acids (2008-05-06),

Title: The Innovative Journey of Eric L Meggers

Introduction: Eric L Meggers is a renowned inventor based in Philadelphia, PA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Eric L Meggers holds several patents in the areas of electronics, software, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Eric L Meggers has worked with leading tech companies, research institutions, and universities, consistently pushing the boundaries of what is possible in the world of inventions.

Collaborations: Throughout his career, Eric L Meggers has collaborated with top inventors, patent attorneys, and companies, fostering a culture of innovation and excellence in all his projects.

Conclusion: Eric L Meggers continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of turning ideas into reality.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…